Avacta Group PLC Investor Briefing
September 29 2014 - 2:01AM
RNS Non-Regulatory
TIDMAVCT
Avacta Group PLC
29 September 2014
29 September 2014
Avacta Group plc
("Avacta" or the "Group")
Investor Results Briefing
Avacta Group plc (AIM: AVCT), the global provider of proprietary
diagnostic tools, consumables and reagents for human and animal
healthcare, announces it will be hosting an investor results
presentation on Thursday 16 October 2014 where Alastair Smith, CEO,
Craig Slater, COO and Tim Sykes, CFO will present the Company's
results for its financial year ended 31 July 2014.
The investor event, open to all investors, will be held from
16:30 at the Black Bar, Rocket, 6 Adams Court, EC2N 1DX followed by
drinks and canapés.
For more information or to register to attend, contact Walbrook
PR (contact details are below).
Enquiries:
Avacta Group plc Tel: +44 (0) 844 414
Alastair Smith, Chief Executive Officer 0452
Tim Sykes, Chief Financial Officer www.avacta.com
Numis Securities Limited Tel: +44 (0) 207 260
Michael Meade / Freddie Barnfield - Nominated 1000
Adviser www.numiscorp.com
James Black - Corporate Broking
Media Enquiries Tel: +44 (0) 207 933
Walbrook PR Ltd 8780
Anna Dunphy / Mike Wort avacta@walbrookpr.com
About Avacta Group plc - www.avacta.com
Avacta Group plc is a global provider of innovative
technologies, consumables and reagents for the life science
markets, from drug discovery to diagnostics. Avacta operates
through three divisions:
Avacta Analytical High throughput analysis instrument, Optim,
www.avactaanalytical.com to help reduce the cost and risk of drug development.
Avacta Animal Health Veterinary diagnostics reference laboratory,
www.avactaanimalhealth.com diagnostic kits and newly launched in-clinic
blood analyser, Sensipod.
-------------------------------------------------------
Avacta Life Sciences Novel non-antibody affinity reagents called
www.avactalifesciences.com Affimers, with a wide range of Life Science
applications in diagnostics, drug and biomarker
discover and biotech research and development.
-------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRASEAFMMFLSESU
Avacta (LSE:AVCT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avacta (LSE:AVCT)
Historical Stock Chart
From Sep 2023 to Sep 2024